| # | Title | Journal | Year | Citations |
|---|
| 1 | ‘First World Health Care at Third World Prices’: Globalization, Bioethics and Medical Tourism | BioSocieties | 2007 | 287 |
| 2 | Against pandemic research exceptionalism | Science | 2020 | 253 |
| 3 | Unsuccessful trial accrual and human subjects protections: An empirical analysis of recently closed trials | Clinical Trials | 2015 | 244 |
| 4 | Use of relative and absolute effect measures in reporting health inequalities: structured review | BMJ, The | 2012 | 189 |
| 5 | Setting Global Standards for Stem Cell Research and Clinical Translation: The 2016 ISSCR Guidelines | Stem Cell Reports | 2016 | 172 |
| 6 | Big data, open science and the brain: lessons learned from genomics | Frontiers in Human Neuroscience | 2014 | 122 |
| 7 | Confronting stem cell hype | Science | 2016 | 109 |
| 8 | Caring About Risks | Archives of General Psychiatry | 1997 | 107 |
| 9 | The Scleroderma Patient-centered Intervention Network (SPIN) Cohort: protocol for a cohort multiple randomised controlled trial (cmRCT) design to support trials of psychosocial and rehabilitation interventions in a rare disease context | BMJ Open | 2013 | 104 |
| 10 | Are outcome-adaptive allocation trials ethical? | Clinical Trials | 2015 | 97 |
| 11 | The questionable use of unequal allocation in confirmatory trials | Neurology | 2014 | 93 |
| 12 | Where Have All the Rodents Gone? The Effects of Attrition in Experimental Research on Cancer and Stroke | PLoS Biology | 2016 | 90 |
| 13 | A Difference-in-Differences Approach to Assess the Effect of a Heat Action Plan on Heat-Related Mortality, and Differences in Effectiveness According to Sex, Age, and Socioeconomic Status (Montreal, Quebec) | Environmental Health Perspectives | 2016 | 87 |
| 14 | Reconciling Cognitive and Perceptual Theories of Emotion: A Representational Proposal | Philosophy of Science | 1997 | 78 |
| 15 | Informed consent for MRI and fMRI research: Analysis of a sample of Canadian consent documents | BMC Medical Ethics | 2011 | 75 |
| 16 | Harms From Uninformative Clinical Trials | JAMA - Journal of the American Medical Association | 2019 | 70 |
| 17 | Should preclinical studies be registered? | Nature Biotechnology | 2012 | 68 |
| 18 | Reflections on the Cost of "Low-Cost" Whole Genome Sequencing: Framing the Health Policy Debate | PLoS Biology | 2013 | 67 |
| 19 | Informed Proxy Consent: Communication Between Pediatric Surgeons and Surrogates About Surgery | Pediatrics | 2000 | 63 |
| 20 | Beyond Access vs. Protection in Trials of Innovative Therapies | Science | 2010 | 63 |
| 21 | Indentity, Prudential Concern, and Extended Lives | Bioethics | 2002 | 62 |
| 22 | Cross-border dental care: 'dental tourism' and patient mobility | British Dental Journal | 2008 | 62 |
| 23 | Untreated Pain, Narcotics Regulation, and Global Health Ideologies | PLoS Medicine | 2013 | 62 |
| 24 | Disability weights in the global burden of disease 2010 study: two steps forward, one step back? | Bulletin of the World Health Organization | 2014 | 62 |
| 25 | Medical tourism: family medicine and international health-related travel | Canadian Family Physician | 2007 | 62 |
| 26 | Preclinical efficacy studies in investigator brochures: Do they enable risk–benefit assessment? | PLoS Biology | 2018 | 55 |
| 27 | Informed consent documents do not encourage good-quality decision making | Journal of Clinical Epidemiology | 2012 | 53 |
| 28 | The ethics of human gene transfer | Nature Reviews Genetics | 2008 | 51 |
| 29 | The influence of popular media on perceptions of personal and population risk in possible disease outbreaks | Health, Risk and Society | 2013 | 51 |
| 30 | ETHICS BEYOND BORDERS: HOW HEALTH PROFESSIONALS EXPERIENCE ETHICS IN HUMANITARIAN ASSISTANCE AND DEVELOPMENT WORK | Developing World Bioethics | 2008 | 46 |
| 31 | Benefit, Risk, and Outcomes in Drug Development: A Systematic Review of Sunitinib | Journal of the National Cancer Institute | 2016 | 46 |
| 32 | Are doctors altruistic? | Journal of Medical Ethics | 2002 | 43 |
| 33 | Do Genetic Relationships Create Moral Obligations in Organ Transplantation? | Cambridge Quarterly of Healthcare Ethics | 2002 | 42 |
| 34 | Anti-aging science: The emergence, maintenance, and enhancement of a discipline | Journal of Aging Studies | 2008 | 41 |
| 35 | Bioidentical hormones, menopausal women, and the lure of the “natural” in U.S. anti-aging medicine | Social Science and Medicine | 2015 | 40 |
| 36 | Defining global health as public health somewhere else | BMJ Global Health | 2020 | 39 |
| 37 | The paradox of precision medicine | Nature Reviews Clinical Oncology | 2018 | 38 |
| 38 | Authentic qualitative research and the quest for methodological rigour | Canadian Journal of Nursing Research | 2002 | 38 |
| 39 | Using decision aids may improve informed consent for research | Contemporary Clinical Trials | 2010 | 34 |
| 40 | Potential harms from legalization of recreational cannabis use in Canada | Canadian Journal of Public Health | 2019 | 34 |
| 41 | Clinical intuition versus statistics: different modes of tacit knowledge in clinical epidemiology and evidence-based medicine | Theoretical Medicine and Bioethics | 2009 | 33 |
| 42 | Increasing efficiency of preclinical research by group sequential designs | PLoS Biology | 2017 | 33 |
| 43 | Inefficiencies and Patient Burdens in the Development of the Targeted Cancer Drug Sorafenib: A Systematic Review | PLoS Biology | 2017 | 33 |
| 44 | A meta-analysis of threats to valid clinical inference in preclinical research of sunitinib | ELife | 2015 | 33 |
| 45 | Rethinking Research Ethics: The Case of Postmarketing Trials | Science | 2012 | 32 |
| 46 | Assessing risk/benefit for trials using preclinical evidence: a proposal | Journal of Medical Ethics | 2016 | 31 |
| 47 | Risk and surrogate benefit for pediatric Phase I trials in oncology: A systematic review with meta-analysis | PLoS Medicine | 2018 | 31 |
| 48 | Are "Anti-Aging Medicine" and "Successful Aging" Two Sides of the Same Coin? Views of Anti-Aging Practitioners | Journals of Gerontology - Series B Psychological Sciences and Social Sciences | 2013 | 29 |
| 49 | Gatekeepers or Intermediaries? The Role of Clinicians in Commercial Genomic Testing | PLoS ONE | 2014 | 29 |
| 50 | Apolipoprotein E Genotyping for Pharmacogenetic Purposes in Alzheimer's Disease: Emerging Ethical Issues | Canadian Journal of Psychiatry | 2000 | 27 |
